Forte Biosciences Stock Analysis

Forte Stock Analysis Notes

About 80.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 16.38. Forte Biosciences last dividend was issued on the 16th of June 2020. The entity had 1:25 split on the 28th of August 2024. Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. Forte Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people. To learn more about Forte Biosciences call Paul Wagner at 310 618 6994 or check out https://www.fortebiorx.com.

Forte Biosciences Investment Alerts

Forte Biosciences Upcoming and Recent Events

Forte Largest EPS Surprises

View All Earnings Estimates

Forte Biosciences Environmental, Social, and Governance (ESG) Scores

Forte Stock Institutional Investors

Note, although Forte Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Forte Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.23 M.

Forte Profitablity

Management Efficiency

Forte Biosciences has return on total asset (ROA) of (0.6766) % which means that it has lost $0.6766 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.374) %, meaning that it created substantial loss on money invested by shareholders. Forte Biosciences' management efficiency ratios could be used to measure how well Forte Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.98 in 2025. Return On Capital Employed is likely to drop to -0.87 in 2025. At this time, Forte Biosciences' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 831.9 K in 2025, whereas Non Current Assets Total are likely to drop slightly above 558.3 K in 2025.

Technical Drivers

As of the 23rd of March, Forte Biosciences shows the Variance of 56.06, standard deviation of 7.49, and Mean Deviation of 5.58. Forte Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Forte Biosciences Price Movement Analysis

Forte Biosciences Insider Trading Activities

Forte Biosciences Outstanding Bonds

Forte Biosciences Predictive Daily Indicators

Forte Biosciences Corporate Filings

Forte Biosciences Forecast Models

Forte Biosciences' time-series forecasting models are one of many Forte Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Forte Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Forte Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Forte shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Forte Biosciences. By using and applying Forte Stock analysis, traders can create a robust methodology for identifying Forte entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Forte analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Forte analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Forte Biosciences stock analysis indicators help investors evaluate how Forte Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Forte Biosciences shares will generate the highest return on investment. By understating and applying Forte Biosciences stock analysis, traders can identify Forte Biosciences position entry and exit signals to maximize returns.

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.